Banco BBVA Argentina S.A. (BME:XBBAR)

Ligand Pharmaceuticals Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 8, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	2,918	4,340	1,217	1,473	1,177	927
Market Cap Growth	106.63%	256.53%	-17.39%	25.21%	26.92%	-27.63%
Last Close Price	4.22	5.18	1.58	1.59	1.14	0.83
PE Ratio	8.97	13.11	3.04	1.52	7.51	3.23
PS Ratio	1.22	1.31	0.25	0.22	0.47	0.33
PB Ratio	1.20	1.77	0.35	0.25	0.43	0.61
P/FCF Ratio	-	-	-	-	0.59	-
P/OCF Ratio	-	-	-	-	0.56	-
Debt / Equity Ratio	0.56	0.48	0.24	0.29	0.10	0.38
Debt / FCF Ratio	-	-	-	-	0.13	-
Return on Equity (ROE)	15.62%	12.50%	16.94%	24.77%	7.69%	22.78%
Return on Assets (ROA)	3.16%	2.55%	3.70%	4.45%	1.20%	3.58%
Earnings Yield	11.15%	7.63%	32.94%	65.67%	13.32%	30.99%
FCF Yield	-159.59%	-115.23%	-619.89%	-771.04%	168.85%	-284.69%
Dividend Yield	0.49%	-	49.81%	-	9.40%	13.33%
Payout Ratio	24.01%	25.65%	0.17%	4.38%	-	-
Buyback Yield / Dilution	-	-	-	-	-	-0.01%
Total Shareholder Return	0.49%	-	49.81%	-	9.40%	13.32%

Source: S&P Global Market Intelligence. Banks template. Financial Sources.